AMD3100

Welcome to the Brand page for “AMD3100”, which is offered here for Pharmaceutical and medicinal preparations for the treatment of hiv, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular disease, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, and elevation of white blood cells;anormed 3100;.

Its status is currently believed to be active. Its class is unavailable. “AMD3100” is believed to be currently owned by “Genzyme Corporation”.

Owner:
GENZYME CORPORATION
Owner Details
Description:
Pharmaceutical and medicinal preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular disease, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, and elevation of white blood cells;ANORMED 3100;
Categories: PHARMACEUTICAL MEDICINAL PREPARATIONS